| NCT06828861 | ARD-101 for Treatment of PWS: The Hunger Elimination or Reduction Objective Trial | RECRUITING | PHASE3 | 2024-12-20 | 2026-04 | 2026-03 |
| NCT06126653 | A Study to Evaluate ARD-501 in Patients With Autism Spectrum Disorder | COMPLETED | PHASE2 | 2024-08-01 | 2025-01-13 | 2025-01-13 |
| NCT07197034 | The Hunger Elimination or Reduction Objective (HERO ) Open -Label Extension (OLE) Trial | RECRUITING | PHASE3 | 2024-07-23 | 2027-04 | 2027-03 |
| NCT05153434 | A Study of Oral ARD-101 in Patients With Prader-Willi Syndrome | COMPLETED | PHASE2 | 2022-05-27 | 2024-09-24 | 2024-09-24 |
| NCT05215847 | Study to Evaluate ARD-101 in Adults Receiving Bariatric Surgery | COMPLETED | PHASE2 | 2022-03-01 | 2023-02-03 | 2023-02-03 |
| NCT05121441 | Study to Evaluate ARD-101 in Adults With Obesity | COMPLETED | PHASE2 | 2021-11-15 | 2022-11-09 | 2022-11-09 |